Navigation Links
Research!America asks Congress to support embryonic stem cell research now
Date:9/8/2010

WASHINGTONSeptember 8, 2010Research!America today called on Congress to take legislative action that will allow federal funding for human embryonic stem cell research to proceed, in light of U.S. District Judge Royce Lamberth's refusal yesterday to lift his recent injunction on federally funded research using embryonic stem cells.

Research!America strongly supports the Stem Cell Research Advancement Act (H.R. 4808) introduced in March 2010 by Representatives Diana DeGette (D-CO) and Mike Castle (R-DE) that would allow federal funding for ethical research using human embryonic stem cells.

Research!America's chair, former Illinois Congressman John Edward Porter, said, "Diana DeGette and Mike Castle continue to lead this issue. They have a bill in the House now that would bring a clear legislative solution and allow embryonic stem cell research to move forward without further legal challenges or shifts in the political landscape. It is absolutely critical that Congress pass this legislation quickly to minimize the devastating scientific and economic consequences of the current injunction. The timeline for potential new treatments for millions of patients has been thrown into limbo, and American jobs and even entire labs are at risk. To date the NIH has invested $546 million in human embryonic stem cell research, and much of the return on that investment will be lost if this research cannot move forward."

Research!America's president and CEO Mary Woolley added, "Human embryonic stem cell research offers hope to millions suffering from disease and disability in the U.S. and around the world. An August 2010 Research!America poll found that fully 70% of Americans favor expanded federal funding for research using embryonic stem cells. What this shows is that support for embryonic stem cell research goes even beyond patients and their families to include the broad majority of Americans. If enough of our elected members of Congress hear from that majority, they will take action."


'/>"/>

Contact: Eva Maciejewski
emaciejewski@researchamerica.org
571-482-2712
Research!America
Source:Eurekalert

Related biology news :

1. Take advantage of reduced pre-registration rates for the IOF World Congress on Osteoporosis
2. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
3. Less than one month to opening of world’s largest global congress on osteoporosis
4. 17th Annual Congress on Womens Health convenes
5. World Congress on Osteoporosis 2010 -- IOFWCO-ECCEO10 to be held in Florence
6. Mobile Communication Market Opens up for Biometrics - Precise Biometrics Awarded 1st Prize at GSMA World Mobile Congress
7. World Congress on Osteoporosis 2010 presents outstanding scientific program
8. CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda
9. 22nd Congress of the European College of Neuropsychopharmacology
10. 22nd Congress of the European College of Neuropsychopharmacology, Sept. 12-16, 2009, Turkey
11. Last chance for media to pre-register for Europes largest cancer congress: ECCO15-ESMO34
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... ... Back pain relief technology is now available without a prescription at What ... relief for WAR members. , This spinal restoration platform boasts utilization of technology that ... suffering from chronic back pain. , What A Relief Back Pain Centers ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, ... Drug Administration (FDA) has accepted Mylan,s biologics license application ... through the 351(k) pathway. This product is a proposed ... certain HER2-positive breast cancers. The anticipated FDA goal date ...
(Date:1/11/2017)... , Jan. 11, 2017  GenVec, Inc. ... delivery company, announced today that its chief scientific ... a talk entitled  "AdenoVerse™ platform for translational development ... Biotech Showcase at the upcoming Phacilitate Cell & ... Miami , Florida.  Dr. Brough,s presentation will ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology: